In the present study, we discovered that CTZ and LOR significantly reduced the activation of the PI3K/p-Akt pathway brought about by acetic acid injection; consequently, these antihistamines demonstrated a promising potential therapeutic intervention point for induced ulcerative colitis and inflammatory bowel disease generally. Here, AKT1 is linked to inflammatory bowel disease.